Accretive Health, Inc. announced that its Board of Directors has appointed Joseph Flanagan, currently President and Chief Operating Officer of Accretive Health, as President, Chief Executive Officer and member of the Board, effective immediately. Dr. Emad Rizk and the Board of Directors have mutually agreed for Dr. Rizk to step down from his positions as CEO and member of the Board. Dr. Rizk will be available over the next several weeks to help ensure a smooth transition.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.82 USD | -0.17% | -1.66% | +11.83% |
Apr. 18 | R1 RCM's Q1 Results to Focus on Strategic Alternatives, Change Cyberattack, RBC Says | MT |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.83% | 4.97B | |
-14.92% | 84.87B | |
+13.30% | 83.08B | |
+10.92% | 29.4B | |
-12.71% | 16.72B | |
-3.06% | 16.4B | |
-2.63% | 15.04B | |
-3.97% | 11.88B | |
-1.42% | 11.88B | |
-31.75% | 11.86B |
- Stock Market
- Equities
- RCM Stock
- News R1 RCM Inc.
- Accretive Health, Inc. Announces Management Changes